Mitochondrial inhibitor 3‐nitroproprionic acid enhances oxidative modification of alpha‐synuclein in a transgenic mouse model of multiple system atrophy
- 29 April 2009
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 87 (12), 2728-2739
- https://doi.org/10.1002/jnr.22089
Abstract
Multiple system atrophy (MSA) is a progressive neurodegenerative disease characterized by autonomic failure, parkinsonism, cerebellar ataxia, and oligodendrocytic accumulation of alpha‐synuclein (αsyn). Oxidative stress has been linked to neuronal death in MSA and the mitochondrial toxin 3‐nitropropionic acid (3NP) is known to enhance the motor deficits and neurodegeneration in transgenic mice models of MSA. However, the effect of 3NP administration on αsyn itself has not been studied. In this context, we examined the neuropathological effects of 3NP administration in αsyn transgenic mice expressing human αsyn (hαsyn) under the control of the myelin basic protein (MBP) promoter and the effect of this administration on posttranslational modifications of αsyn, on levels of total αsyn, and on its solubility. We demonstrate that 3NP administration altered levels of nitrated and oxidized αsyn in the MBP‐hαsyn tg while not affecting global levels of phosphorylated or total αsyn. 3NP administration also exaggerated neurological deficits in the MBP‐hαsyn tg mice, resulting in widespread neuronal degeneration and behavioral impairment.This publication has 41 references indexed in Scilit:
- Phosphorylation Does Not Prompt, Nor Prevent, the Formation of -synuclein Toxic Species in a Rat Model of Parkinson's DiseaseHuman Molecular Genetics, 2008
- Rifampicin reduces α-synuclein in a transgenic mouse model of multiple system atrophyNeuroReport, 2008
- Characterization of antibodies that selectively detect α-synuclein in pathological inclusionsActa Neuropathologica, 2008
- The phosphorylation state of Ser-129 in human α-synuclein determines neurodegeneration in a rat model of Parkinson diseaseProceedings of the National Academy of Sciences of the United States of America, 2008
- Calpain-Cleavage of α-Synuclein: Connecting Proteolytic Processing to Disease-Linked AggregationThe American Journal of Pathology, 2007
- Cleavage of α-Synuclein by Calpain: Potential Role in Degradation of Fibrillized and Nitrated Species of α-SynucleinBiochemistry, 2005
- α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson diseaseNature Neuroscience, 2005
- Case–control study of multiple system atrophyMovement Disorders, 2004
- Oxidative Modifications of α‐SynucleinAnnals of the New York Academy of Sciences, 2003
- Environmental— occupational risk factors and familial associations in multiple system atrophy: A preliminary investigationClinical Autonomic Research, 1991